1. Characterization of immune response against Mycobacterium marinum infection in the main hematopoietic organ of adult zebrafish (Danio rerio). (February 2020) Authors: Harjula, Sanna-Kaisa E.; Saralahti, Anni K.; Ojanen, Markus J.T.; Rantapero, Tommi; Uusi-Mäkelä, Meri I.E.; Nykter, Matti; Lohi, Olli; Parikka, Mataleena; Rämet, Mika Journal: Developmental and comparative immunology Issue: Volume 103(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DNA vaccination boosts Bacillus Calmette–Guérin protection against mycobacterial infection in zebrafish. Issue 1 (January 2016) Authors: Oksanen, Kaisa E.; Myllymäki, Henna; Ahava, Maarit J.; Mäkinen, Leena; Parikka, Mataleena; Rämet, Mika Journal: Developmental and comparative immunology Issue: Volume 54:Issue 1(2016) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In vitro inhibition of Mycobacterium tuberculosis β-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos. (1st January 2020) Authors: Aspatwar, Ashok; Hammaren, Milka; Parikka, Mataleena; Parkkila, Seppo; Carta, Fabrizio; Bozdag, Murat; Vullo, Daniela; Supuran, Claudiu T. Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 35:Number 1(2020) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes. (1st January 2018) Authors: Aspatwar, Ashok; Becker, Holger M.; Parvathaneni, Nanda Kumar; Hammaren, Milka; Svorjova, Aleksandra; Barker, Harlan; Supuran, Claudiu T.; Dubois, Ludwig; Lambin, Philippe; Parikka, Mataleena; Parkkila, Seppo; Winum, Jean-Yves Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 33:Number 1(2018) Page Start: 1064 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Randomized controlled and double‐blinded study of Caphosol versus saline oral rinses in pediatric patients with cancer. Issue 10 (29th July 2020) Authors: Immonen, Egle; Aine, Liisa; Nikkilä, Atte; Parikka, Mataleena; Grönroos, Marika; Vepsäläinen, Kaisa; Palmu, Sauli; Helminen, Mika; Peltomäki, Timo; Lohi, Olli Journal: Pediatric blood & cancer Issue: Volume 67:Issue 10(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome. Issue 13 (9th November 2020) Authors: Laukkanen, Saara; Oksa, Laura; Nikkilä, Atte; Lahnalampi, Mari; Parikka, Mataleena; Seki, Masafumi; Takita, Junko; Degerman, Sofie; de Bock, Charles E.; Heinäniemi, Merja; Lohi, Olli Journal: Leukemia & lymphoma Issue: Volume 61:Issue 13(2020) Page Start: 3089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The zebrafish as a model for paediatric diseases. (7th September 2012) Authors: Lohi, Olli; Parikka, Mataleena; Rämet, Mika Journal: Acta pædiatrica Issue: Volume 102:Number 2(2013:Feb.) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis. (1st January 2017) Authors: Aspatwar, Ashok; Hammarén, Milka; Koskinen, Sanni; Luukinen, Bruno; Barker, Harlan; Carta, Fabrizio; Supuran, Claudiu T.; Parikka, Mataleena; Parkkila, Seppo Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 32:Number 1(2017) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗